Avere Therapeutics secures $500 million in a Private Placement to advance its oral IL-23 therapy AVR-001, supported by a notable investor syndicate.
Amount Raised
$500 Million
Round Type
Post-IPO Equity
Investors
Description
Avere Therapeutics announced a $500 million private placement from leading healthcare investors to bolster its balance sheet and support the development of AVR-001. The funding is expected to fully finance Avere's operating plan into 2029. This follows a previously disclosed $320 million concurrent private investment. The combined proceeds will help advance Avere's lead program.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Avere Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Rejuvenation Technologies raised an undisclosed amount on September 24, 2026.
- Kasvu Therapeutics raised $34M (Series A) on September 24, 2026.
- ViferaXS raised $14M (Series A) on September 23, 2026.
- Kinoxis Therapeutics raised $5M (Seed) on September 23, 2026.
- Aqua Medical raised an undisclosed amount (Series B) on September 23, 2026.
- Anacalypsis Therapeutics raised an undisclosed amount (Pre-Seed) on September 21, 2026.
Who to call at Avere Therapeutics, and when
A new round usually means Avere Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avere Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avere Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avere Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avere Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avere Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.